S. Korea’s kimchi exports in 2020 hit record high Updated: 2020-12-20 12:11:31 KST
The pandemic has raised consumer interest in foods that boost the immune system, which has apparently helped South Korea’s exports of kimchi reach a new alltime high. According to the…
Cybersecurity research looks to guard networks from ‘insider threats’
Research News Experts mine computer system data to find potential vulnerabilities October 15, 2015 Even the best-protected, most sensitive computer networks resemble castles: They have walls to ward off outside…
Infographic: How NSF-supported research keeps you safe online
Research News NSF investments in interdisciplinary research helped develop many of the web’s basic protections October 19, 2015 Over the last two decades, the National Science Foundation (NSF) has funded…
S. Korea honors remains of 514 fallen Korean War soldiers Updated: 2020-12-18 17:22:45 KST
South Korea held a ceremony on Friday to honor more than five-hundred soldiers killed in the Korean War whose remains were recently recovered from the DMZ and from battlefields in…
FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer | FDA News
For Immediate Release: December 18, 2020 Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors…
S. Korea inks free trade pact with Indonesia Updated: 2020-12-18 18:06:16 KST
South Korea on Friday signed the Comprehensive Economic Partnership Agreement with Indonesia. ‘CEPA’, as it is also known, will enable South Korean businesses to have access to the largest market…
FDA Approves Prosthetic Implant for Above-the-Knee Amputations | FDA News
For Immediate Release: December 18, 2020 The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed…
FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer | FDA News
For Immediate Release: December 18, 2020 Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. “Today’s approval marks the…